Cargando…
Characterization of CD44 variant expression in head and neck squamous cell carcinomas
CD44 is a complex family of molecules, associated with aggressive malignancies and cancer stem cells. However, the role of CD44 variants in tumor progression and treatment resistance is not clear. In this study, the expression of CD44 and its variants was assessed in head and neck squamous cell carc...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967078/ https://www.ncbi.nlm.nih.gov/pubmed/24122205 http://dx.doi.org/10.1007/s13277-013-1272-3 |
_version_ | 1782308977535614976 |
---|---|
author | Spiegelberg, D. Kuku, G. Selvaraju, R. Nestor, M. |
author_facet | Spiegelberg, D. Kuku, G. Selvaraju, R. Nestor, M. |
author_sort | Spiegelberg, D. |
collection | PubMed |
description | CD44 is a complex family of molecules, associated with aggressive malignancies and cancer stem cells. However, the role of CD44 variants in tumor progression and treatment resistance is not clear. In this study, the expression of CD44 and its variants was assessed in head and neck squamous cell carcinomas (HNSCC). Furthermore, subpopulations of cells expressing high amounts of CD44 variants were identified and characterized, for e.g., cell cycle phase and radioresistance. Results revealed high and homogenous CD44 and CD44v7 expression in four cell lines and CD44v4 and CD44v6 in three cell lines. CD44v3 was highly expressed in two cell lines, whereas CD44v5, CD44v7/8, CD44v10, CD133, and CD24 demonstrated no or moderate expression. Moreover, a subpopulation of very high CD44v4 expression was identified, which is independent of cell phase, demonstrating increased proliferation and radioresistance. In cell starvation experiments designed to enrich for cancer stem cells, a large population with dramatically increased expression of CD44, CD44v3, CD44v6, and CD44v7 was formed. Expression was independent of cell phase, and cells demonstrated increased radioresistance and migration rate. Our results demonstrate that the heterogeneity of tumor cells has important clinical implications for the treatment of HNSCC and that some of the CD44 variants may be associated with increased radioresistance. Highly expressed CD44 variants could make interesting candidates for selective cancer targeting. |
format | Online Article Text |
id | pubmed-3967078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-39670782014-03-27 Characterization of CD44 variant expression in head and neck squamous cell carcinomas Spiegelberg, D. Kuku, G. Selvaraju, R. Nestor, M. Tumour Biol Research Article CD44 is a complex family of molecules, associated with aggressive malignancies and cancer stem cells. However, the role of CD44 variants in tumor progression and treatment resistance is not clear. In this study, the expression of CD44 and its variants was assessed in head and neck squamous cell carcinomas (HNSCC). Furthermore, subpopulations of cells expressing high amounts of CD44 variants were identified and characterized, for e.g., cell cycle phase and radioresistance. Results revealed high and homogenous CD44 and CD44v7 expression in four cell lines and CD44v4 and CD44v6 in three cell lines. CD44v3 was highly expressed in two cell lines, whereas CD44v5, CD44v7/8, CD44v10, CD133, and CD24 demonstrated no or moderate expression. Moreover, a subpopulation of very high CD44v4 expression was identified, which is independent of cell phase, demonstrating increased proliferation and radioresistance. In cell starvation experiments designed to enrich for cancer stem cells, a large population with dramatically increased expression of CD44, CD44v3, CD44v6, and CD44v7 was formed. Expression was independent of cell phase, and cells demonstrated increased radioresistance and migration rate. Our results demonstrate that the heterogeneity of tumor cells has important clinical implications for the treatment of HNSCC and that some of the CD44 variants may be associated with increased radioresistance. Highly expressed CD44 variants could make interesting candidates for selective cancer targeting. Springer Netherlands 2013-10-12 /pmc/articles/PMC3967078/ /pubmed/24122205 http://dx.doi.org/10.1007/s13277-013-1272-3 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Research Article Spiegelberg, D. Kuku, G. Selvaraju, R. Nestor, M. Characterization of CD44 variant expression in head and neck squamous cell carcinomas |
title | Characterization of CD44 variant expression in head and neck squamous cell carcinomas |
title_full | Characterization of CD44 variant expression in head and neck squamous cell carcinomas |
title_fullStr | Characterization of CD44 variant expression in head and neck squamous cell carcinomas |
title_full_unstemmed | Characterization of CD44 variant expression in head and neck squamous cell carcinomas |
title_short | Characterization of CD44 variant expression in head and neck squamous cell carcinomas |
title_sort | characterization of cd44 variant expression in head and neck squamous cell carcinomas |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967078/ https://www.ncbi.nlm.nih.gov/pubmed/24122205 http://dx.doi.org/10.1007/s13277-013-1272-3 |
work_keys_str_mv | AT spiegelbergd characterizationofcd44variantexpressioninheadandnecksquamouscellcarcinomas AT kukug characterizationofcd44variantexpressioninheadandnecksquamouscellcarcinomas AT selvarajur characterizationofcd44variantexpressioninheadandnecksquamouscellcarcinomas AT nestorm characterizationofcd44variantexpressioninheadandnecksquamouscellcarcinomas |